Get the Stockscreener App
8.775
1.92%
0.165
Passage Bio Inc stock is traded at $8.775, with a volume of 2,216.
It is up +1.92% in the last 24 hours and down -30.25% over the past month.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
See More
Previous Close:
$8.61
Open:
$8.59
24h Volume:
2,216
Relative Volume:
0.04
Market Cap:
$27.89M
Revenue:
-
Net Income/Loss:
$-68.80M
P/E Ratio:
-7.50
EPS:
-1.17
Net Cash Flow:
$-59.06M
1W Performance:
-0.40%
1M Performance:
-30.25%
6M Performance:
+16.38%
1Y Performance:
+1,572%
1-Day Range:
$8.59
$8.775
1-Week Range:
$8.33
$9.66
52-Week Range:
$0.257
$20.00
Passage Bio Inc Stock (PASG) Company Profile
Name
Passage Bio Inc
Sector
Industry
Phone
(267) 866-0312
Address
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Compare PASG vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
8.775 | 27.37M | 0 | -68.80M | -59.06M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
485.71 | 121.15B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
785.50 | 82.43B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
828.96 | 52.25B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.68 | 44.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
366.48 | 40.07B | 4.98B | 69.60M | 525.67M | 0.5198 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-10-26 | Resumed | Chardan Capital Markets | Buy |
| Nov-29-24 | Resumed | Wedbush | Outperform |
| Sep-03-24 | Initiated | Rodman & Renshaw | Buy |
| Mar-08-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-19-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-01-21 | Initiated | Raymond James | Outperform |
| Jun-15-21 | Initiated | BTIG Research | Buy |
| Mar-04-21 | Upgrade | Goldman | Neutral → Buy |
| Feb-04-21 | Initiated | Guggenheim | Buy |
| Jan-25-21 | Initiated | Wedbush | Outperform |
| Jan-04-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-11-20 | Initiated | Citigroup | Neutral |
| Aug-14-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-25-20 | Downgrade | Goldman | Buy → Neutral |
| Mar-25-20 | Initiated | Chardan Capital Markets | Buy |
| Mar-24-20 | Initiated | Cowen | Outperform |
| Mar-24-20 | Initiated | Goldman | Buy |
| Mar-24-20 | Initiated | JP Morgan | Overweight |
View All
Passage Bio Inc Stock (PASG) Latest News
Moving Averages: What is the earnings history of Passage Bio Inc2025 Analyst Calls & Risk Managed Investment Entry Signals - baoquankhu1.vn
Nasdaq Moves: Can Passage Bio Inc. reach all time highs this yearBear Alert & Expert Approved Trade Ideas - mfd.ru
Can Passage Bio Inc. stock hit record highs againInsider Buying & Advanced Technical Analysis Signals - mfd.ru
Passage Bio to Participate in Upcoming Investor Conferences - Caledonian Record
Biotech Passage Bio lines up Oppenheimer and TD Cowen investor talks - Stock Titan
What downside risks could hit Goldman Sachs Equal Weight U.S. stockJuly 2025 Catalysts & Accurate Entry/Exit Alerts - mfd.ru
Can Passage Bio Inc. outperform in the next rallyJuly 2025 Opening Moves & Free Daily Entry Point Trade Alerts - mfd.ru
Will BioMarin Pharmaceutical Inc. (BM8) stock maintain strong growth2025 Earnings Impact & Weekly Chart Analysis and Guides - mfd.ru
Is Passage Bio Inc.’s ROIC above industry averageJuly 2025 Rallies & Entry Point Strategy Guides - mfd.ru
Why Putnam ETF Trust Putnam BioRevolution stock appeals to dividend investorsMarket Volume Summary & Low Risk Growth Stock Ideas - mfd.ru
Should I invest in Passage Bio Inc before earningsQuarterly Market Summary & AI Driven Price Predictions - baoquankhu1.vn
Passage Bio (NASDAQ:PASG) Coverage Initiated by Analysts at Chardan Capital - Defense World
Brokerages Set Passage Bio, Inc. (NASDAQ:PASG) Target Price at $42.67 - Defense World
Retail Surge: What is the dividend yield of Passage Bio Inc2025 Market Overview & Risk Controlled Swing Alerts - baoquankhu1.vn
Can Passage Bio Inc. reach all time highs this yearPortfolio Gains Summary & Risk Controlled Daily Plans - mfd.ru
Gm1 Gangliosidosis Treatment Market Witness Booming Growth: - openPR.com
Earnings Miss: Is PAYC stock a buy or sellTrade Risk Summary & Growth Oriented Trade Recommendations - baoquankhu1.vn
Gap Down: How does Passage Bio Inc perform in inflationary periodsWeekly Stock Summary & Long-Term Investment Growth Plans - baoquankhu1.vn
Aug Analyst Calls: Is Information Services Group Inc likely to announce a buyback2025 Risk Factors & High Conviction Buy Zone Picks - baoquankhu1.vn
Market Rankings: Why is Royce Small Cap Trust Inc stock going downProduct Launch & Low Drawdown Investment Ideas - baoquankhu1.vn
Insider Trends: Is TETRA Technologies Inc. a cyclical or defensive stockMarket Sentiment Report & Trade Opportunity Analysis Reports - baoquankhu1.vn
Death Cross: Why is Peloton Interactive Inc stock going up2025 Fundamental Recap & Smart Investment Allocation Insights - baoquankhu1.vn
Is Cardlytics Inc. stock overvalued by current metrics2025 Risk Factors & Accurate Technical Buy Alerts - bollywoodhelpline.com
Aug Volume: Is RYAAY stock forming a cup and handleAnalyst Downgrade & Risk Managed Investment Strategies - baoquankhu1.vn
US Market Wrap: How do insiders feel about VSCOJuly 2025 WrapUp & Fast Entry High Yield Tips - baoquankhu1.vn
Is Passage Bio Incs ROIC above industry averageEarnings Risk Report & Stepwise Trade Signal Implementation - baoquankhu1.vn
Sentiment Watch: Does Passage Bio Inc have pricing powerJuly 2025 Snapshot & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Institution Moves: Will NVEC stock reach all time highs in 20252025 Growth vs Value & Daily Market Momentum Tracking - Bộ Nội Vụ
Insider Selling: Passage Bio (NASDAQ:PASG) CEO Sells $75,161.44 in Stock - MarketBeat
Passage Bio, Inc. (NASDAQ:PASG) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Does Passage Bio Inc. stock trade at a discount to peers2025 Macro Impact & Real-Time Chart Breakout Alerts - Улправда
Why BTSG stock is rated strong buyMarket Volume Summary & Consistent Profit Focused Trading Strategies - Улправда
Will Passage Bio Inc. stock benefit from green energy trendsJuly 2025 Fed Impact & Low Risk High Reward Trade Ideas - Улправда
Can Passage Bio Inc. stock withstand economic slowdown2025 Technical Overview & Expert Curated Trade Ideas - Улправда
Why Virtu Financial Inc. Class stock remains stableInflation Watch & Verified Swing Trading Watchlists - Улправда
Is It Too Late to Sell Telecanor Global LimitedCurrency Fluctuation Impact & Affordable Market Insights - bollywoodhelpline.com
2026 world cup mexico semifinals playmakers counter attacking analysis and odds expert opinionWeekly Trading Summary & Free Expert Verified Stock Movement Alerts - Улправда
Is IDRV stock among top earnings plays2025 Stock Rankings & Weekly High Potential Stock Alerts - Улправда
Published on: 2026-01-08 17:15:22 - Улправда
Why Passage Bio Inc. stock is rated strong buyGrowth Stock Opportunities & Fast Growing Trading Ideas - Улправда
Passage Bio (NASDAQ:PASG) Trading Down 2.3%Here's What Happened - MarketBeat
Passage Bio (NASDAQ:PASG) Trading Down 2.3% – Here’s What Happened - Defense World
Candlestick Signal Suggests Reversal in QVC Exports LimitedTrading Volume Surges & Free Tools to Monitor Market Corrections - bollywoodhelpline.com
Aug Highlights: Is Ares Management Corporation stock attractive after correction2025 Retail Activity & Stock Portfolio Risk Management - moha.gov.vn
Passage Bio Reports Promising Data in Trial for Frontotemporal Dementia Treatment - MSN
Quicktouch Technologies Limited Bounces Off Moving Average SupportDividend Stock Watch & Small Investment Big Gains - earlytimes.in
Earnings Chart Overlay Points to Rajesh Power Services Limited UpsideStock Price Divergence & Free Dynamic Capital Growth - bollywoodhelpline.com
Trendlines Converge — Decision Point for Affle (India) LimitedPrice Action Analysis & Free Turn Volatility To Profit - bollywoodhelpline.com
Is Maxposure Limited in Accumulation Phase NowSector ETF Performance & High Return Stock Ideas - bollywoodhelpline.com
Live Scanner Shows Breakout on Paras Defence and Space Technologies LimitedEarnings Volatility Patterns & Big Gains Low Budget - bollywoodhelpline.com
Spright Agro Limited (531205) Gets Regulatory ApprovalCandlestick Pattern Analysis & Set Up Real-Time Alerts – It’s Free - bollywoodhelpline.com
Passage Bio Inc Stock (PASG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Passage Bio Inc Stock (PASG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Borthwick Kathleen | CFO |
Jan 08 '26 |
Sale |
18.44 |
2,062 |
38,022 |
5,402 |
0.09%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):